A detailed history of Tidemark, LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Tidemark, LLC holds 60 shares of ZTS stock, worth $10,604. This represents 0.0% of its overall portfolio holdings.

Number of Shares
60
Previous 90 33.33%
Holding current value
$10,604
Previous $15.6 Million 99.93%
% of portfolio
0.0%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$172.58 - $196.48 $5,177 - $5,894
-30 Reduced 33.33%
60 $11,000
Q1 2024

May 13, 2024

SELL
$165.67 - $199.94 $4,970 - $5,998
-30 Reduced 25.0%
90 $15.2 Million
Q4 2023

Feb 09, 2024

BUY
$151.44 - $200.09 $18,172 - $24,010
120 New
120 $23.7 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.7B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Tidemark, LLC Portfolio

Follow Tidemark, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tidemark, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tidemark, LLC with notifications on news.